US-based Smiths Medical has gained US marketing rights for its CADD-Solis variable infusion profile (VIP) ambulatory infusion system, following the US Food and Drug Administration (FDA) approval.

View original post here:
Smiths Medical wins FDA nod for multi-therapy infusion system